Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI

Press, D. Z., Musaeus, C. S., Zhao, L., Breton, J. M., Shafi, M. M., Dai, W., & Alsop, D. C. (2023). Levetiracetam Increases Hippocampal Blood Flow in Alzheimer’s Disease as Measured by Arterial Spin Labelling MRI. Journal of Alzheimer’s Disease, 93(3), 939–948. https://doi.org/10.3233/jad-220614

Authors:

Daniel Zvi Press

Christian Sandoe Musaeus

Jocelyn M. Breton

Mouhsin M. Shafi

Li Zhao

Weiying Dai

David C. Alsop

Affiliated Authors:

Jocelyn M. Breton

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Psychiatry

Author Keywords:

alzheimer's disease

arterial spin labeling mri

epilepsy

epileptiform activity

levetiracetam

randomized controlled trial

elink

Publication Type:

Article

Unique ID:

10.3233/JAD-220614

PMID:

37125545

DOI:

10.3233/JAD-220614

Journal:

Journal of Alzheimer's Disease

Publication Date:

2023-01-01

Data Source:

Web of Science

Source Link:

View Web of Science Record

Record Created:

Friday, December 13, 2024 - 13:13